RMAM
ATRS

Raab & Moskowitz Asset Management’s Antares Pharma, Inc. ATRS Stock Holding History

Raab & Moskowitz Asset Management’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,000
Closed -$3K – 406
2014
Q4 		$3K Buy
+1,000
New +$2.25K ﹤0.01% 429

Other funds holding ATRS

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WHI
William Harris Investors Chicago, Illinois $347M AUM 3.53% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Raab & Moskowitz Asset Management's ATRS Position: Q1 2015 in Review

Raab & Moskowitz Asset Management sold out of Antares Pharma, Inc. (ATRS) in Q1 2015, closing a stake of 1,000 shares — an estimated $3K sold.

Raab & Moskowitz Asset Management first reported a position in ATRS in Q4 2014 and held it in 1 quarter. The position peaked at $3K in Q4 2014. 81 funds tracked by Wall St. Rank hold ATRS as of Q1 2015.

  • Raab & Moskowitz Asset Management reported no remaining Antares Pharma, Inc. position as of Q1 2015 after selling out during the quarter.
  • Raab & Moskowitz Asset Management sold 1,000 Antares Pharma, Inc. shares in Q1 2015, an estimated $3K.
  • Raab & Moskowitz Asset Management first reported a position in Antares Pharma, Inc. in Q4 2014 and held it in 1 quarter.
  • Raab & Moskowitz Asset Management's Antares Pharma, Inc. position peaked at $3K in Q4 2014.
  • 81 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q1 2015.

Based on Raab & Moskowitz Asset Management's 13F filing for Q1 2015, filed 12 May 2015.